According to filings with the U.S. Securities and Exchange Commission, Selkirk Pharma is raising $25,000,002.00 in new funding. Sources indicate that as part of senior management President, Partick Haffey played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Selkirk Pharma
Selkirk is a new aseptic Fill and Finish CMO located in the healthcare hub of the Pacific Northwest, and we are focused on providing the most reliable aseptic fill and finish services available. Our facility is purpose-built for contract manufacturing with unidirectional process flows, electronic batch records and the most advanced SKAN isolators and Bausch and Stroebel filling equipment. At Selkirk we believe that the safety and availability of drug products are the most important priorities for our clients. Selkirk was founded, designed, and built by a team of industry professionals with a passion for creating a newly imagined, first-in-class CMO facility. This group has grown into a multidisciplinary team of Quality and Manufacturing experts with an average of 20 years industry experience.

To learn more about Selkirk Pharma, visit http://www.selkirkpharma.com/

Contact:
Partick Haffey, President
509-340-9909
https://www.linkedin.com/in/patrick-haffey-844b0845/

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.